841 related articles for article (PubMed ID: 21419759)
1. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
3. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
[TBL] [Abstract][Full Text] [Related]
4. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
6. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
Feo F; Frau M; Tomasi ML; Brozzetti S; Pascale RM
Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
[TBL] [Abstract][Full Text] [Related]
8. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
9. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
10. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
15. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
16. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
[TBL] [Abstract][Full Text] [Related]
17. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
[TBL] [Abstract][Full Text] [Related]
18. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
20. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
